Postnatal changes of cytokines in premature infants with or without funisitis

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 27, Issue 15, 2014, Pages 1545-1549

  Nishimaki, Shigeru ^a   Shima, Yoshio ^b   Sato, Miho ^a   An, Hiromi ^a   Kadota, Keisuke ^a   Yokota, Shumpei ^a  

^a YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Chorioamnionitis; Fetal inflammatory response syndrome; Hypercytokinemia; Interleukin 1 ; Interleukin 6; Interleukin 8

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; IMMUNOGLOBULIN M; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN DERIVATIVE;

ARTICLE; BLOOD SAMPLING; CHORIOAMNIONITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE STORM; DISEASE ASSOCIATION; FUNISITIS; HUMAN; HUMAN TISSUE; INFANT; LEUKOCYTE COUNT; PREMATURITY; PROTEIN BLOOD LEVEL; RISK; UMBILICAL CORD BLOOD; BLOOD; CASE CONTROL STUDY; FEMALE; NEWBORN; PREGNANCY;

CASE-CONTROL STUDIES; CHORIOAMNIONITIS; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTERLEUKINS; PREGNANCY;

EID: 84907057749     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2013.867321     Document Type: Article

References (24)

1. Gomez R, Romero R, Ghezzi F, et al. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998;179:194-202.
2. Watterberg KL, Demers LM, Scott SM, et al. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996;97:210-15.
3. Yoon BH, Roberto R, Jun JK, et al. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-α, interleukin-1β, and interleukin- 8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1997;177:825-30.
4. Ghezzi F, Gomez R, Romero R, et al. Elevated interleukin-8 concentrations in amniotic fluid of mothers whose neonates subsequently develop bronchopulmonary dysplasia. Eur J Obstet Gynecol Reprod Biol 1998;78:5-10.
5. Romero R, Maymon E, Pacora P, et al. Further observations on the fetal inflammatory response syndrome: a potential homeostatic role for the soluble receptors of tumor necrosis factor α. Am J Obstet Gynecol 2000;183:1070-7.
6. Yoon BH, Romero R, Park JS, et al. Fetal exposure to an intraamniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 2000;182:675-81.
7. Büscher U, Chen FC, Pitzen A, et al. Il-1β, Il-6, Il-8 and G-CSF in the diagnosis of early-onset neonatal infections. J Perinat Med 2000;28:383-8.
8. Minagawa K, Tsuji Y, Ueda H, et al. Possible correlation between high levels of IL-18 in the cord blood of pre-term infants and neonatal development of periventricular leukomalacia and cerebral palsy. Cytokine 2002;17:164-70.
9. Ng PC, Li K, Wong RPO, et al. Proinflammatory and antiinflammatory cytokine responses in preterm infants with systemic infections. Arch Dis Child Fetal Neonatal Ed 2003;88:F209-13.
10. Mittendorf R, Montag AG, MacMillan W, et al. Components of the systemic fetal inflammatory response syndrome as predictors of impaired neurologic outcomes in children. Am J Obstet Gynecol 2003;188:1438-46.
11. Mestan K, Yu Y, Thorsen P, et al. Cord blood biomarkers of the fetal inflammatory response. J Matern Fetal Neonatal Med 2009; 22:379-87.
12. Ambalavanan N, Carlo WA, D'Angio CT, et al. Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants. Pediatrics 2009;123:1132-41.
13. Bose C, Laughon M, Allred EN, et al. Blood protein concentrations in the first two postnatal weeks that predict bronchopulmonary dysplasia among infants born before the 28th week of gestation. Pediatr Res 2011;69:347-53.
14. An H, Nishimaki S, Ohyama M, et al. Interleukin-6, interleukin-8 and soluble tumor necrosis factor receptor-I in the cord blood as predictors of chronic lung disease in premature infants. Am J Obstet Gynecol 2004;191:1649-54.
15. Sato M, Mori M, Nishimaki S, et al. Soluble tumor necrosis factor receptor-I in preterm infants with chronic lung disease. Pediatr Int 2010;52:268-72.
16. 2-microglobulin in premature infants with chorioamnionitis and chronic lung disease. J Pediatr 2003;143:120-2.
17. Nishimaki S, Sato M, An H, et al. Comparison of markers for fetal inflammatory response syndrome: fetal blood interleukin-6 and neonatal urinary β2-microglobulin. J Obstet Gynaecol Res 2009;35: 472-6.
18. Shima Y, Nishimaki S, Nakajima M, et al. Urinary β-2-microglobulin as an alternative marker for fetal inflammatory response and development of bronchopulmonary dysplasia in premature infants. J Perinatol 2011;31:330-4.
19. Nishimaki S, Shima Y, Sato M, et al. Urinary β2-microglobulin in very preterm neonates with chorioamnionitis. Pediatr Nephrol 2011;26:2185-91.
20. Rovira N, Alarcon A, Iriondo M, et al. Impact of histological chorioamnionitis, funisitis and clinical chorioamnionitis on neurodevelopmental outcome of preterm infants. Early Hum Dev 2011; 87:253-7.
21. Salas AA, Faye-Petersen OM, Peralta-Carcelen M, et al. Histological characteristics of the fetal inflammatory response associated with neurodevelopmental impairment and death in extremely infants. J Pediatr 2013;163:652-7. e1-2.
22. Redline RW. Inflammatory responses in the placenta and umbilical cord. Semin Fetal Neonatal Med 2006;11:296-301.
23. Aatonen R, Heikkinen T, Hakala K, et al. Transfer of proinflammatory cytokines across term placenta. Obstet Gynecol 2005; 106:802-7.
24. Assadi F. Neonatal nephritic syndrome associated with placental transmission of proinflammatory cytokines. Pediatr Nephrol 2011; 26:469-71.